Regional brain cortical thinning and systemic inflammation in older persons without dementia

Journal of the American Geriatrics Society

Volumn 58, Issue 9, 2010, Pages 1823-1825

  Fleischman, Debra A ^a   Arfanakis, Konstantinos ^a,b   Kelly, Jeremiah F ^a   Rajendran, Niranjini ^a   Buchman, Aron S ^a   Morris, Martha C ^c   Barnes, Lisa L ^a   Bennett, David A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Illinois Institute of Technology   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER;

AGING; ALZHEIMER DISEASE; BRAIN CORTEX ATROPHY; DISEASE MARKER; HUMAN; INFLAMMATION; LETTER; NERVE DEGENERATION; BRAIN CORTEX; COMPLICATION; DEMENTIA; DIFFERENTIAL DIAGNOSIS; FEMALE; MALE; NEURODEGENERATIVE DISEASES; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; VERY ELDERLY;

AGED, 80 AND OVER; AGING; CEREBRAL CORTEX; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MALE; NEURODEGENERATIVE DISEASES;

EID: 77956327471     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2010.03049.x     Document Type: Letter

References (10)

1. Salat DH, Buckner RL, Snyder AZ et al. Thinning of the cerebral cortex in aging. Cerebral Cortex 2004 14 : 721 730.
2. Dickerson BC, Bakkour A, Salat DH et al. The cortical signature of Alzheimer's disease: Regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individual. Cereb Cortex 2009 19 : 497 510.
3. Bakkour A, Morris JC, Dickerson BC. The cortical signature of prodromal AD: Regional thinning predicts mild AD dementia. Neurology 2009 72 : 1048 1055.
4. Perry VH. The influence of systemic inflammation on inflammation in the brain: Implications for chronic neurodegenerative disease. Brain Behav Immun 2004 18 : 407 413.
5. Bennett DA, Schneider JA, Aggarwal NT et al. Prediction rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort compared to standard practice in a clinic-based cohort study. Neuroepidemiology 2006 27 : 169 176.
6. Akiyama H the Neuroinflammation Working Group. Inflammation in Alzheimer's disease. Neurobiol Aging 2000 21 : 383 421.
7. Marsland AL, Gianaros PJ, Abramowitch SM et al. Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biol Psychiatry 2008 15 : 484 490.
8. Van Dijk EJ, Prins ND, Vermeer SE et al. C-reactive protein and cerebral small-vessel disease: The Rotterdam Scan Study. Circulation 2005 112 : 900 905.
9. Jefferson A, Massaro JM, Wolf PA et al. Inflammatory biomarkers are associated with total brain volume: The Framingham Heart Study. Neurology 2007 68 : 1032 1038.
10. Semmler A, Okulla T, Sastre M et al. Systemic inflammation induces apoptosis with variable vulnerability of different brain regions. J Chem Neuroanat 2005 30 : 144 157.